Picard Medical (PMI) Equity Average (2024 - 2026)

Picard Medical has reported Equity Average for 3 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 102.52% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 102.52% YoY), and the FY2025 full-year result was -$20.1 million, changed N/A from the prior year.
• Equity Average for Q1 2026 stood at $1.2 million, down from $5.9 million in the prior quarter.
• The five-year high for Equity Average was $5.9 million in Q4 2025, with the low at -$51.7 million in Q2 2025.
• Historically, Equity Average has averaged -$26.7 million across 3 years, with a median of -$32.5 million in 2024.
• The largest YoY upside for Equity Average was 114.81% in 2025 against a maximum downside of 28.46% in 2025.
• Picard Medical's Equity Average stood at -$39.7 million in 2024, then soared by 114.81% to $5.9 million in 2025, then slumped by 80.09% to $1.2 million in 2026.
• The last three Equity Average figures came in at $1.2 million (Q1 2026), $5.9 million (Q4 2025), and -$23.3 million (Q3 2025), per Business Quant data.